Abstract
DL-8280 was administered to 12 cases consisting of 2 cases with pneumonia, 1 case with secondary respiratory tract infection by lung cancer, 2 cases with acute colitis, 1 case with chronic cystitis, 2 cases with asymptomatic bacteriuria, 3 cases with acute pyelonephritis, 1 case with acute cholecystitis. Efficacy was evaluated to be excellent in 1 case, good in 9 cases, fair in 1 case, poor in 1 case. DL-8280 was effective in 10 out of 12 cases in total and the effectiveness rate was 83.3%.
No distinct side effect was observed.
